跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Wogonin
首页
药物
Wogonin
Wogonin
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
COMPOSITIONS AND METHODS FOR TREATING PAIN WITH WOGONIN
EP 3737370 A4
申请人: UNIV BRIGHAM YOUNG
优先权: 2018
CN
EP
US
WO
6 件公开
WOGONIN FOR THE PREVENTION AND THERAPY OF CARDIAC HYPERTROPHY
EP 2593099 A1
申请人: DKFZ KREBSFORSCHUNGSZENTRUM
优先权: 2010
EP
US
WO
3 件公开
Inhibitor or promoter of uridinediphosphate glucuronosyltransferase 2B (UGT2B)
CN 1820743 A
申请人: HU OLIVER YOA PU
优先权: 2005
CN
WO
3 件公开
Extract of mad-dog skullcap
US 2007190189 A1
申请人: GAFNER STEFAN
优先权: 2003
US
3 件公开
Compositions and Methods for Pain Reduction
US 2013136811 A1
申请人: SCHACHTER STEVEN C
优先权: 2010
US
WO
2 件公开
PHARMACEUTICAL COMPOSITION CONTAINING WOGONIN AS AN ACTIVE INGREDIENT FOR PREVENTING OR TREATING ASTHMA
US 2014228427 A1
申请人: OH SEI RYANG
优先权: 2011
US
WO
2 件公开
USE OF ORAL-NASAL INHALATION TYPE WOGONIN FORMULATION IN THE PREPARATION OF DRUGS TREATING BRAIN GLIOMA
WO 2025050440 A1
申请人: NANJING QINLING PHARMACEUTICAL TECH COMPANY LIMITED
优先权: 2023
CN
WO
2 件公开
Compound for treatment of anxiety and methods of preparation and use thereof
CN 1671680 A
申请人: NATURON LTD
优先权: 2002
CN
2 件公开
US 7183314 B1
申请人: NATURON LTD
优先权: 2001
US
COMBINATORIAL THERAPY FOR USE IN INDUCING IMMUNOGENIC CELL DEATH IN CANCER CELLS
US 2023172956 A1
申请人: HARTMANN JAMES
优先权: 2022
US
2 件公开
FLAVONES AS INDUCIBLE NITRIC OXIDE SYNTHASE INHIBITORS, CYCLOOXYGENASE-2 INHIBITORS AND POTASSIUM CHANNEL ACTIVATORS
WO 0130342 A9
申请人: UNIV SOUTHERN ILLINOIS
优先权: 1999
WO
US 6806257 B1
申请人: UNIV SOUTHERN ILLINOIS
优先权: 2000
US
第 1 / 10 页
上一页
下一页
药物
反馈